These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1791768)
21. Immunohistochemical staining of von Willebrand factor in endometrium of women during the first year of Norplant implants use. Au CL; Affandi B; Rogers PA Contraception; 1994 Nov; 50(5):477-89. PubMed ID: 7859456 [TBL] [Abstract][Full Text] [Related]
22. Ultra-low-dose continuous combined estradiol and dydrogesterone in postmenopausal women: A pooled safety and tolerability analysis. Tatarchuk T; Stevenson JC; Yu Q; Kahler E; Graziano Custodio M; Ren M; Nappi RE; Karpova V; Simoncini T Gynecol Endocrinol; 2024 Dec; 40(1):2375577. PubMed ID: 38976762 [No Abstract] [Full Text] [Related]
24. Estradiol and dydrogesterone. A review of their combined use as hormone replacement therapy in postmenopausal women. Foster RH; Balfour JA Drugs Aging; 1997 Oct; 11(4):309-32. PubMed ID: 9342560 [TBL] [Abstract][Full Text] [Related]
25. [Dihydrogesterone vs. medroxyprogesterone acetate in association with transdermal estradiol in postmenopausal substitution treatment]. Delzanno G; Paoletti R; Gaudiano L; Bertinetti G; Ventrella CA; Dell'Elce C Minerva Ginecol; 1994 Apr; 46(4):179-82. PubMed ID: 8065591 [TBL] [Abstract][Full Text] [Related]
27. The effect of HRT on cerebral haemodynamics and cerebral vasomotor reactivity in post-menopausal women. Bain CA; Walters MR; Lees KR; Lumsden MA Hum Reprod; 2004 Oct; 19(10):2411-4. PubMed ID: 15284214 [TBL] [Abstract][Full Text] [Related]
28. Cyclical dydrogesterone in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study. Panay N; Pritsch M; Alt J Gynecol Endocrinol; 2007 Nov; 23(11):611-8. PubMed ID: 17891596 [TBL] [Abstract][Full Text] [Related]
29. Beneficial effects on serum lipoproteins by 17 beta-oestradiol-dydrogesterone therapy in postmenopausal women; a prospective study. van der Mooren MJ; Demacker PN; Thomas CM; Rolland R Eur J Obstet Gynecol Reprod Biol; 1992 Nov; 47(2):153-60. PubMed ID: 1459329 [TBL] [Abstract][Full Text] [Related]
30. Low incidence of endometrial hyperplasia with acceptable bleeding patterns in women taking sequential hormone replacement therapy with dydrogesterone. Bergeron C; Fox H Gynecol Endocrinol; 2000 Aug; 14(4):275-81. PubMed ID: 11075299 [TBL] [Abstract][Full Text] [Related]
31. Clinical audit of estradiol implant therapy: Long duration of action and implications in non-hysterectomised women. Wheatley S; Bell RJ; Stuckey BG; Robinson PJ; Davis SR Maturitas; 2016 Dec; 94():84-86. PubMed ID: 27823750 [TBL] [Abstract][Full Text] [Related]
32. Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women. Kwok S; Charlton-Menys V; Pemberton P; McElduff P; Durrington PN Maturitas; 2006 Mar; 53(4):439-46. PubMed ID: 16139447 [TBL] [Abstract][Full Text] [Related]
33. Effects of dydrogesterone on the oestrogenized postmenopausal endometrium. Lane G; Siddle NC; Ryder TA; Pryse-Davies J; King RJ; Whitehead MI Br J Obstet Gynaecol; 1986 Jan; 93(1):55-62. PubMed ID: 3002419 [TBL] [Abstract][Full Text] [Related]
35. Long-term effects of low-dose 17beta-estradiol plus dydrogesterone on 24-h ambulatory blood pressure in healthy postmenopausal women: a 1-year, randomized, prospective study. Kaya C; Cengiz SD; Cengiz B; Akgun G Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():62-7. PubMed ID: 17943541 [TBL] [Abstract][Full Text] [Related]
36. Analysis of the contribution of dydrogesterone to bone turnover changes in postmenopausal women commencing hormone replacement therapy. Tobias JH; Clarke S; Mitchell K; Robins S; Amer H; Fraser WD J Clin Endocrinol Metab; 2001 Mar; 86(3):1194-8. PubMed ID: 11238508 [TBL] [Abstract][Full Text] [Related]
37. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium. Schindler AE Maturitas; 2009 Dec; 65 Suppl 1():S3-11. PubMed ID: 19969432 [TBL] [Abstract][Full Text] [Related]
38. 25 mg oestradiol implants--the dosage of first choice for subcutaneous oestrogen replacement therapy? Owen EJ; Siddle NC; McGarrigle HT; Pugh MA Br J Obstet Gynaecol; 1992 Aug; 99(8):671-5. PubMed ID: 1327094 [TBL] [Abstract][Full Text] [Related]
40. Effects of 15 months of 17 beta-estradiol and dydrogesterone on systolic cardiac function according to quantitative and Doppler echocardiography in healthy postmenopausal women. Kessel H; Kamp O; Kenemans P; Mijatovic V; van Baal WM; Visser CA; van der Mooren MJ Am J Obstet Gynecol; 2001 Apr; 184(5):910-6. PubMed ID: 11303198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]